Newsbenzinga
Eloxx Pharmaceuticals Says FDA Cleared IND For Exaluren In Nonsense-Mutation Polycystic Kidney Disease, Phase 2 Topline Data Expected 1H 2029
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…